Deepank Utkhede is Chief Process Biochemist at Vantage and has over 20 years of experience in pharmaceutical development and manufacturing. His background in the pharmaceutical industry has helped with designing robust and commercially scalable hemp extraction and finished product manufacturing processes at Vantage. Deepank has worked extensively in the development and production of pharmaceutical products including injectables, topicals, and oral products. Deepank has played a large role in the development of Vantage’s 62,000 sq ft. manufacturing facilities located in Greeley, Colorado and the attainment of the company’s ICH Q7 and WHO GMP certifications.
OVERVIEW OF THE MARKET The global cannabidiol (CBD) market was valued at 4.9 billion USD in 2021 and is projected to attain a value of 47.22 billion USD by 2028 at a compound annual growth rate (CAGR) of 21.3% during...
Cannabidiol (CBD) has taken the wellness industry by storm. CBD is a natural compound found in the Cannabis sativa L. plant (cannabis) that has gained popularity in recent years due to its potential therapeutic benefits, versatility, and non-intoxicating effects. Part...
To meet the growing demands of the market, CBD manufacturers and sellers eagerly expand their range of CBD products, offering customers more versatility and flexibility. Buyers get to choose what form of CBD application is the most favorable to them....
Water-soluble CBD can be found in many CBD products available on the market, including CBD tinctures and CBD edibles. Still, many consumers are not aware of what water-soluble CBD is and how it differs from traditional CBD solutions. And since...
Scalability vs. Growth While the terms ‘scalability’ and ‘growth’ are often used interchangeably in common business parlance, as metrics in manufacturing, the two are quite distinct. Indeed, growth, which is essentially recognized as an increase in revenue, is both the...
Hemp-derived Cannabinoids – A New Era The 2018 Farm Bill succeeded in federally legalizing the cultivation of ‘hemp’ by removing it from DEA (Drug Enforcement Administration) oversight. Under the Federal Food, Drug, and Cosmetic Act and the Public Health Service...
GMPs, or ‘Good Manufacturing Practices’, are a set of practices which are necessary in order for a product to conform to the guidelines of various regulatory agencies around the world. GMPs mainly affect pharmaceutical products, tobacco products, cosmetics, and foods....